Metraipolis › archive › dc_736e892bfe75

Antibody-drug conjugates for primary brain tumors — Europe PMC PMID:42180101

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42180101
DOI
10.3389/fonc.2026.1811494
License (as archived)
solo-consultazione
Archived
2026-11-02T13:57:57.148Z
SHA-256 of the archived text
5ca24f9c147d1fa587eb509e120f47d7cdfb234f0d9669be07174247331ec3f9
Stable URL of this page
https://metraipolis.com/documento/dc_736e892bfe75

How to cite

Antibody-drug conjugates for primary brain tumors — Europe PMC PMID:42180101 — Europe PMC (en), https://europepmc.org/article/MED/42180101 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_736e892bfe75 (Metraipolis archive dc_736e892bfe75, sha256 5ca24f9c147d1fa587eb509e120f47d7cdfb234f0d9669be07174247331ec3f9)
BibTeX
@misc{dc736e892bfe75,
  title = {Antibody-drug conjugates for primary brain tumors — Europe PMC PMID:42180101},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180101},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_736e892bfe75; sha256 5ca24f9c147d1fa587eb509e120f47d7cdfb234f0d9669be07174247331ec3f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180101. Agents can read the archived copy with the MCP tool read_document.